140 related articles for article (PubMed ID: 8898251)
41. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
Paniello RC; Barlow J; Serna JS
Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
[TBL] [Abstract][Full Text] [Related]
42. Botulinum toxin injections for the treatment of spasmodic dysphonia.
Watts CC; Whurr R; Nye C
Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
[TBL] [Abstract][Full Text] [Related]
43. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
[TBL] [Abstract][Full Text] [Related]
44. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
Rodriquez AA; Ford CN; Bless DM; Harmon RL
Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
[TBL] [Abstract][Full Text] [Related]
45. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
Holzer SE; Ludlow CL
Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
[TBL] [Abstract][Full Text] [Related]
46. A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.
Zwirner P; Murry T; Woodson GE
Eur Arch Otorhinolaryngol; 1993; 250(5):271-6. PubMed ID: 8217128
[TBL] [Abstract][Full Text] [Related]
47. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
48. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
Davidson BJ; Ludlow CL
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
[TBL] [Abstract][Full Text] [Related]
49. Phonatory air flow characteristics of adductor spasmodic dysphonia and muscle tension dysphonia.
Higgins MB; Chait DH; Schulte L
J Speech Lang Hear Res; 1999 Feb; 42(1):101-11. PubMed ID: 10025547
[TBL] [Abstract][Full Text] [Related]
50. [Spasmodic dysphonia. Investigation and therapeutic methods].
Marion MH; Klap P; Perrin A; Elbaz E
Rev Neurol (Paris); 1992; 148(3):180-3. PubMed ID: 1604131
[TBL] [Abstract][Full Text] [Related]
51. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
[TBL] [Abstract][Full Text] [Related]
52. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
[TBL] [Abstract][Full Text] [Related]
53. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
Ludlow CL; Naunton RF; Fujita M; Sedory SE
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
[TBL] [Abstract][Full Text] [Related]
54. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
Benninger MS; Gardner G; Grywalski C
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
[TBL] [Abstract][Full Text] [Related]
55. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
56. Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction.
Schönweiler R; Wohlfarth K; Dengler R; Ptok M
Laryngoscope; 1998 Jan; 108(1 Pt 1):55-63. PubMed ID: 9432068
[TBL] [Abstract][Full Text] [Related]
57. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
Boutsen F; Cannito MP; Taylor M; Bender B
J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
[TBL] [Abstract][Full Text] [Related]
58. Spasmodic dysphonia. Emotional status and botulinum toxin treatment.
Murry T; Cannito MP; Woodson GE
Arch Otolaryngol Head Neck Surg; 1994 Mar; 120(3):310-6. PubMed ID: 8123241
[TBL] [Abstract][Full Text] [Related]
59. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
Bielamowicz S; Ludlow CL
Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
[TBL] [Abstract][Full Text] [Related]
60. Acoustic measures of symptoms in abductor spasmodic dysphonia.
Edgar JD; Sapienza CM; Bidus K; Ludlow CL
J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]